Merck

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$16,286,000
$16,324,000
$17,183,000
$15,800,000
Gross Profit
13,342,000
11,507,000
12,989,000
11,953,000
EBITDA
-1,884,000
8,626,000
8,535,000
7,415,000
EBIT
6,160,000
7,463,000
6,359,000
Net Income
-4,240,000
2,963,000
5,785,000
4,427,000
Net Change In Cash
16,286,000
16,324,000
17,183,000
15,800,000
Free Cash Flow
2,927,000
1,824,000
6,835,000
2,529,000
Cash
5,327,000
14,565,000
18,169,000
8,007,000
Basic Shares
2,472,000
2,488,000
2,498,000
2,513,000

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$64,926,000
$64,168,000
$60,115,000
$59,283,000
Gross Profit
46,731,000
48,975,000
43,989,000
41,872,000
EBITDA
29,324,000
25,706,000
6,907,000
21,315,000
EBIT
23,486,000
21,207,000
3,035,000
17,406,000
Net Income
18,254,000
17,117,000
365,000
14,519,000
Net Change In Cash
64,926,000
64,168,000
60,115,000
59,283,000
Cost of Revenue
5,016,000
Free Cash Flow
12,360,000
18,096,000
9,143,000
14,707,000
Cash
14,565,000
13,242,000
6,841,000
12,694,000
Basic Shares
2,507,000
2,541,000
2,547,000
2,542,000

Earnings Calls

QuarterEPS
2026-03-31
-$1.28
2025-12-31
$1.19
2025-09-30
$2.58
2025-06-30
$2.13